<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>THE TUMOR IMMUNE MICROENVIRONMENT AS A KEY DETERMINANT OF DISEASE PROGRESSION AND THERAPEUTIC RESPONSE IN HPV-ASSOCIATED CERVICAL CANCER</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Rajabova Nodira Makhmud kizi</mods:namePart><mods:namePart type="family">Rajabova Nodira Makhmud kizi</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Karimova Nargiza Mansurovna</mods:namePart><mods:namePart type="family">Karimova Nargiza Mansurovna</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>This thesis synthesizes current concepts of HPV-driven immune remodeling across disease stages, highlights TIME features associated with progression and outcome, and discusses actionable translational strategies—including biomarker-guided immunotherapy combinations, microenvironment reprogramming, and multi-omics profiling—to improve responses and durability of control.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-01-08</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>